Decision maker priorities for providing antiretroviral therapy in HIV-infected South Africans: a qualitative assessment.
In resource-limited settings, successful HIV treatment scale-up has been tempered by reports of funding shortfalls. We aimed to determine the priorities, including ethical considerations, of decision makers for HIV antiretroviral programs. We conducted qualitative interviews with 12 decision makers, identified using purposive sampling. Respondents engaged in one-on-one, semi-structured interviews. We developed an interview guide to direct questions about key priorities and motivations for decision making about HIV antiretroviral programs. We evaluated textual data from the interviews to identify themes. Among 12 respondents, 10 (83%) lived and worked in South Africa. Respondents came from Western Cape, Gauteng, and KwaZulu-Natal provinces and worked primarily in urban settings. The respondents supported prioritizing individual patients based on treatment adherence, pregnancy status to prevent maternal-to-child HIV transmission and/or orphans, and severity of illness. However, priorities based on severity of illness varied, with first-come/first-serve, prioritization of the most severely ill, and prioritization of the least severely ill discussed. Respondents opposed prioritizing based on patient socioeconomic characteristics. Other priorities included the number of persons receiving treatment; how treated patients are distributed in the population (e.g., urban/rural); and treatment policy (e.g., number of antiretroviral regimens). Motivations included humanitarian concerns; personal responsibility for individual patients; and clinical outcomes (e.g., patient-level morbidity/mortality, saving lives) and/or social outcomes (e.g., restoring patients as functional family members). Decision makers have a wide range of priorities for antiretroviral provision in South Africa, and the motivations underlying these priorities suggest at times conflicting ethical considerations for providing HIV treatment when resources are limited.
Department of Healthcare Policy and Research, Virginia Commonwealth University School of Medicine, Richmond, USA. adkimmel@vcu.edu
April D
AD
Kimmel
Norman
N
Daniels
Theresa S
TS
Betancourt
Robin
R
Wood
Lisa A
LA
Prosser
D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000191:economics; D003657:Decision Making / Q000941:ethics; D005260:Female; D006679:HIV Seropositivity / Q000188:drug therapy* / Q000453:epidemiology; D007722:Health Knowledge, Attitudes, Practice; D006292:Health Priorities / Q000941:ethics; D006297:Health Services Accessibility / Q000191:economics / Q000941:ethics*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D008297:Male; D009042:Motivation / Q000941:ethics; D011050:Policy Making; D011247:Pregnancy; D036301:Qualitative Research; D013019:South Africa / Q000453:epidemiology
D019380:Anti-HIV Agents